InvestorsHub Logo
Followers 99
Posts 6738
Boards Moderated 0
Alias Born 01/25/2014

Re: None

Tuesday, 10/03/2023 10:03:54 AM

Tuesday, October 03, 2023 10:03:54 AM

Post# of 98531
(2) The Company has embarked on an exciting initiative to create clinical trials focused on psychedelics. The aim is to develop and bring to market a diverse range of safe and effective therapeutic products based on psychedelics. To support this endeavor, the Company has initiated preliminary discussions with a reputable contract research organization based in Canada. Furthermore, the Company is actively exploring the possibility of expanding its team by adding experienced professionals with a proven track record in running successful clinical trials and bringing products to market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHMD News